News Daily News GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease L.A. McKeown June 12, 2025
Presentation ACC 2025 Extended Anticoagulant Treatment With A Reduced Versus Full Dose Apixaban In Patients With Cancer-associated Venous Thromboembolism: The API-CAT Study Presenter: Isabelle Mahé March 29, 2025
News Conference News ACC 2025 Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT Caitlin E. Cox March 29, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2025 Shelley Wood February 28, 2025
News Industry News Genomadix Inc. Announces Health Canada License for Rapid Genetic Test to Aid Therapy Selection for Stroke and Cardiovascular Disease Patients January 30, 2025